Contents

Current Pharmaceutical Design, Volume 9 - Number 25

Preface [Hot topic: Anti-Cancer Drugs (Executive Editor : Elke Bergmann-Leitner)]

, 9(25): i

Elke Bergmann-Leitner


DOI: 10.2174/1381612033454135




Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?

, 9(25): 2009 - 2023

Elke S. Bergmann-Leitner, Elizabeth H. Duncan and Wolfgang W. Leitner


DOI: 10.2174/1381612033454199




Porphyrins as Radiosensitizing Agents for Solid Neoplasms

, 9(25): 2024 - 2035

M. Schaffer, B. Ertl-Wagner, P. M. Schaffer, U. Kulka, A. Hofstetter, E. Duhmke and G. Jori


DOI: 10.2174/1381612033454153




Bradykinin Antagonists as Anti-Cancer Agents

, 9(25): 2036 - 2042

J. M. Stewart


DOI: 10.2174/1381612033454171




Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia

, 9(25): 2043 - 2059

Markus Warmuth, Robert Damoiseaux, Yi Liu, Doriano Fabbro and Nathanael Gray


DOI: 10.2174/1381612033454126




Novel Protein Targeted Therapy of Metastatic Melanoma

, 9(25): 2060 - 2066

Arthur E. Frankel, Han-Mo Koo, Stephen H. Leppla, Nicholas S. Duesbery and George F. Vande Woude


DOI: 10.2174/1381612033454162




Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention

, 9(25): 2067 - 2077

J. Brtko and J. Thalhamer


DOI: 10.2174/1381612033454144




Recent Developments in the Field of Tumor-Inhibiting Metal Complexes

, 9(25): 2078 - 2089

M. Galanski, V. B. Arion, M. A. Jakupec and B. K. Keppler


DOI: 10.2174/1381612033454180




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science